tiprankstipranks
Trending News
More News >
Grail Inc (GRAL)
:GRAL
US Market
Advertisement

GRAIL Inc (GRAL) Earnings Dates, Call Summary & Reports

Compare
214 Followers

Earnings Data

Report Date
Nov 18, 2025
After Close (Confirmed)
Period Ending
2025 (Q3)
Consensus EPS Forecast
-3.41
Last Year’s EPS
-3.94
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings

Earnings Call Summary

Q2 2025
Earnings Call Date:Aug 12, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call presented a mix of positive developments in commercial growth, clinical trial results, and financial management, alongside operational challenges and high net loss. The positive aspects, including strong revenue growth and clinical trial outcomes, slightly outweigh the lowlights, indicating a cautiously optimistic outlook.
Company Guidance
During GRAIL's second quarter 2025 earnings call, the company highlighted several key performance metrics and financial results. GRAIL reported second-quarter revenue of $35.5 million, an 11% increase from the previous year, with screening revenue accounting for $34.4 million. The company sold over 45,000 Galleri tests in the quarter, contributing to a total of more than 370,000 tests prescribed by over 15,000 healthcare providers since the product's commercial launch in 2021. Galleri's positive predictive value (PPV) was notably higher in the PATHFINDER 2 study compared to the first PATHFINDER study, with a specificity of 99.5% and a cancer signal origin accuracy of 88%. Additionally, GRAIL's cash position was $606.1 million, and it revised its full-year cash burn guidance to no more than $310 million, a decrease of more than 40% compared to 2024. The company also plans to submit detailed PATHFINDER 2 study results for presentation at the ESMO Congress 2025 in October.
Strong Commercial Growth
Galleri test orders grew significantly with more than 45,000 commercial tests sold in Q2, contributing to over 370,000 tests prescribed since its launch in 2021.
Positive Clinical Trial Results
PATHFINDER 2 study showed substantially greater additional cancer detection and a higher positive predictive value compared to the first PATHFINDER study.
Revenue Growth
GRAIL reported Q2 revenue of $35.5 million, an 11% increase from the same period in 2024, with U.S. Galleri revenue up 21%.
Partnership Expansion
GRAIL established new partnerships, including with Rush University System for Health and Everlywell, to expand the availability of Galleri.
Improved Financials
Net loss improved by 93% compared to Q2 2024, with cash burn guidance updated to no more than $310 million for 2025, down from previously projected numbers.

GRAIL Inc (GRAL) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

GRAL Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Nov 18, 2025
2025 (Q3)
-3.41 / -
-3.94
Aug 12, 2025
2025 (Q2)
-3.57 / -3.18
-51.05593.77% (+47.88)
May 13, 2025
2025 (Q1)
-3.99 / -3.10
-7.0556.03% (+3.95)
Feb 20, 2025
2024 (Q4)
-4.97 / -2.89
-6.03952.14% (+3.15)
Nov 12, 2024
2024 (Q3)
-6.43 / -3.94
-28.71186.28% (+24.77)
Aug 13, 2024
2024 (Q2)
- / -51.05
-6.217-721.22% (-44.84)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

GRAL Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Aug 12, 2025
$33.60$33.98+1.13%
May 13, 2025
$42.89$32.89-23.32%
Feb 20, 2025
$47.76$40.73-14.72%
Nov 12, 2024
$15.09$15.92+5.50%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Grail Inc (GRAL) report earnings?
Grail Inc (GRAL) is schdueled to report earning on Nov 18, 2025, After Close (Confirmed).
    What is Grail Inc (GRAL) earnings time?
    Grail Inc (GRAL) earnings time is at Nov 18, 2025, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is GRAL EPS forecast?
          GRAL EPS forecast for the fiscal quarter 2025 (Q3) is -3.41.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis